On the global scale, primary liver cancer (PLC) is the second leading cause of death due to cancer in men, and the third most prevalent cause of death in both sexes. Hepatocellular carcinoma (HCC) accounts for almost 75% of the total cases among primary liver malignancies. Curative operations for HCC include liver resection, ablation, and transplantation. However, a timely diagnosis is required for these operations to be successful. Hepatocarcinogenesis is a multistep process and can be induced by molecular alterations at both the genetic and epigenetic levels. The characteristic pathogenesis mechanisms of HCC are abnormal signal transduction resulting in uncontrolled cell proliferation, loss of apoptosis or programmed cell death, tissue invasion and metastasis allowing the spread of cancer, and finally angiogenesis which leads to the enhanced blood supply of tumors. In addition to epigenetic control of tumorigenesis. The p53 cell-cycle pathway, mutations in oxidative stress pathways, PI3K/AKT/mTOR, and Ras/Raf/MAPK signaling pathways are of great important pathways in HCC pathogenesis. Crosstalk between these pathways may be targeted by anti-cancer medications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.